CSBR - Champions Oncology, Inc.
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice.
As of Aug 14, 2026: spot at $5.06, ATM IV 430.6%, max pain $2.50, net GEX $142.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $68.8M
- Beta
- 0.41
- 52-Week Range
- 4.88-8.74
- CEO
- Robert Brainin
- Employees
- 214
- IPO Date
- Feb 2, 2007
- Exchange
- NASDAQ
What CSBR Looks Like to Options Traders Today
IV rank of 93.1% signals elevated pricing relative to the 1-year history, conditions that typically favor premium-selling structures (credit spreads, iron condors, covered calls); positive net gamma exposure ($142) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes.
What This Page Covers
The CSBR overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked CSBR overview questions
- What is CSBR?
- CSBR is the ticker symbol for Champions Oncology, Inc., a listed security. Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. Listed on NASDAQ. CSBR is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the CSBR options snapshot look like today?
- As of Aug 14, 2026, the CSBR options snapshot shows spot at $5.06, ATM IV 430.6%, IV rank 93.1%, max pain $2.50, net GEX $142, expected move 123.45%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are CSBR's key statistics?
- Champions Oncology, Inc. (CSBR) carries a market capitalization of $68.8M, beta of 0.41 relative to the broader market, 52-week range of 4.88-8.74. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does CSBR belong to?
- Champions Oncology, Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare CSBR's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the CSBR data on this page?
- The options snapshot above is dated Aug 14, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).